Home/SOM Biotech/Rossella Medori, M.D
RM

Rossella Medori, M.D

Chief Medical Officer

SOM Biotech

Therapeutic Areas

SOM Biotech Pipeline

DrugIndicationPhase
SOM3355Huntington's diseasePhase 3
SOM1311Phenylketonuria (PKU)Preclinical
SOM3366Tourette SyndromePreclinical
SOM0226TTR AmyloidosisPhase 2a PoC